| Next 10 |
Ad
AVXL News and Press Anavex Life Sciences Corp.
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
-
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, schizoph...
-
2024-08-06 07:32:00 ET More on Anavex Life Sciences Anavex: An Update To Their Phase 2b/3 Alzheimer's Trial Data Anavex Life Sciences: Short-Lived Spike On Latest Alzheimer's Data Not Surprising Neutral On Anavex: Evaluating The Potential In Neurodegenerative Disease...
-
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated the...
-
Clearwater Paper Corporation (CLW) is expected to report for Q2 2024 Amgen Inc. (AMGN) is expected to report $4.93 for Q2 2024 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.47 for Q2 2024 Axon Enterprise Inc. (AXON) is expected to report $0.55 for Q2 2024 Ame...
-
2024-08-05 18:00:11 ET Major earnings expected before the bell on Tuesday include: Caterpillar ( CAT ) Duke Energy ( DUK ) Marathon Petroleum ( MPC ) Organon ( OGN ) Uber Technologies ( UBER ) Read the full article on Seeking Alpha For...
-
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, schizophr...
-
2024-07-30 19:16:05 ET Summary On Sunday, July 28th, Anavex Life Sciences announced that data from their phase 2b/3 Alzheimer's Disease trial was presented at the 2024 Alzheimer's Association International Conference. New data can be found in the announcement and the corresponding...
-
ANAVEX ® 2-73 corrects directly to humans’ translatable EEG biomarkers in a model of Fragile X Syndrome (FXS) Therapeutic potential to address behavioral and cognitive deficits in individuals with neurodevelopmental disorders Plans advancing to initiate a...
-
2024-07-29 17:34:01 ET More on Anavex Life Sciences Anavex Life Sciences: Short-Lived Spike On Latest Alzheimer's Data Not Surprising Neutral On Anavex: Evaluating The Potential In Neurodegenerative Diseases Anavex Life Sciences announces expansion of leadership team...
-
2024-07-29 13:49:29 ET Summary Anavex Life Sciences shared latest data from its SIGMAR-protein targeting drug Blarcamesine yesterday, in Alzheimer's Disease. On a positive note, data showed clinical decline was slowed by 38.5% in the 50-mg arm, and 34.6% in the 30mg arm. On th...
Stock Information
Get AVXL Alerts
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Ad
-
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, schizoph...
-
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated the...
-
Clearwater Paper Corporation (CLW) is expected to report for Q2 2024 Amgen Inc. (AMGN) is expected to report $4.93 for Q2 2024 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.47 for Q2 2024 Axon Enterprise Inc. (AXON) is expected to report $0.55 for Q2 2024 Ame...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...